Pacific Point Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$589K Hold
872
– – 0.32% 73
2026
Q2
$437K Sell
872
-32
-4% -$15.4K 0.2% 92
2026
Q1
$444K Buy
904
+7
+0.8% +$3.8K 0.23% 93
2025
Q4
$520K Hold
897
– – 0.28% 94
2025
Q3
$435K Buy
897
+22
+3% +$10.2K 0.25% 90
2025
Q2
$355K Hold
875
– – 0.19% 91
2025
Q1
$435K Hold
875
– – 0.24% 84
2024
Q4
$508K Buy
+875
New +$481K 0.31% 77

Other funds holding TMO

Pacific Point Advisors's TMO Position: Q3 2026 in Review

Pacific Point Advisors held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 872 shares worth $589K. The position accounts for 0.32% of the portfolio, ranked #73.

Pacific Point Advisors first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Pacific Point Advisors held 872 shares of Thermo Fisher Scientific worth $589K as of Q3 2026.
  • Pacific Point Advisors left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.32% of Pacific Point Advisors's portfolio in Q3 2026, its #73 holding.
  • Pacific Point Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
  • 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Pacific Point Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.